LobbyingTruetest Medical lobbying by quarter
Truetest Medical's latest lobbying report covers Q2 2026, at under $5,000. Its first report covers Q2 2025; the issues it reports most are Consumer Issues/Safety/Protection and Medical/Disease Research/Clinical Labs.
Truetest Medical
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q2 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2025 | $10K | 1 |
| Q3 2025 | $20K | 1 |
| Q4 2025 | $0 | 1 |
| Q1 2026 | $0 | 1 |
| Q2 2026 | $0 | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Consumer protection and safety$15K · 5 reports
- Medical research and clinical labs$15K · 5 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Food & Drug Administration (FDA)5 reports
- White House Office1 reports
Firms it paid
| Firm | ||
|---|---|---|
| The Vogel Group | $30K | 5 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| ALEXANDER NICHOLAS VOGEL sr | Former Chief Counsel, Senate Majority Leader Bill Frist | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | The Vogel Group | Under $5,000 |
| 04/20for Q1 | The Vogel Group | Under $5,000 |
| 01/20for Q4 2025 | The Vogel Group | Under $5,000 |
| 25/10/20for Q3 2025 | The Vogel Group | $20K |
| 25/07/21for Q2 2025 | The Vogel Group | $10K |
| 25/06/28for Q2 2025 | The Vogel Group | Under $5,000 |